“Onset of Clinical Response with Deucravacitinib in Patients with Moderate to Severe Scalp Psoriasis: A Post Hoc Analysis of the Phase 3b/4 PSORIATYK SCALP Trial” (2025) SKIN The Journal of Cutaneous Medicine, 9(2), p. s539. doi:10.25251/skin.10.supp.539.